INTERNATIONAL ANAL NEOPLASIA SOCIE… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2012

Legal Domicile

Principal Officer

LUIS BARROSO MD

Phone

7204215100

Tax Period

2025-01-01 to 2025-12-31

INTERNATIONAL ANAL NEOPLASIA SOCIETY INC, founded in 2012, is a small nonprofit in the Diseases & Disorders sector that reported $508K in total revenue in fiscal year 2025. Revenue surged 78% from the prior year, signaling strong growth momentum.

Mission

IANS MISSION IS TO PROVIDE A FORUM FOR INDIVIDUALS WITH A BROAD SPECTRUM OF BACKGROUND, VIEWPOINTS AND GEOGRAPHIC ORIGIN, AN EXCHANGE OF IDEAS AND DISSEMINATION OF KNOWLEDGE REGARDING THE PATHOGENESIS, DIAGNOSIS, TREATMENT AND PREVENTION OF ANAL NEOPLASIA.

Program Service Accomplishments

Program 1

Expenses: $285,074 Revenue: $242,680

SCIENTIFIC MEETING - THE 2025 EVENT SHOWCASED INVITED PRESENTATIONS, ABSTRACTS, SMALL GROUP SESSIONS AND A LIVELY SCIENTIFIC INTERCHANGE ON ANAL HPV INFECTION, ANAL SQUAMOUS INTRAEPITHELIAL LESIONS...

Program 2

Expenses: $22,740 Revenue: $28,550

ADVANCED HRA COURSE - THE IANS VIRTUAL ADVANCED HIGH RESOLUTION ANOSCOPY (HRA) COURSE EXPANDS THE ABILITY OF PROVIDERS TO RECOGNIZE AND TREAT ANAL SQUAMOUS INTRAEPITHELIAL LESIONS IN ORDER TO BUILD...

Program 3

Expenses: $30,602 Revenue: $124,595

STANDARD HRA COURSE - THE HIGH RESOLUTION ANOSCOPY (HRA) COURSE SERVES AS A BASIC INTRODUCTION FOR ALL CLINICIANS INTERESTED IN PROVIDING THIS SPECIALIZED PROCEDURE AND WHO WORK WITH POPULATIONS...

STANDARD HRA COURSE - THE HIGH RESOLUTION ANOSCOPY (HRA) COURSE SERVES AS A BASIC INTRODUCTION FOR ALL CLINICIANS INTERESTED IN PROVIDING THIS SPECIALIZED PROCEDURE AND WHO WORK WITH POPULATIONS UNDER CONSIDERATION FOR ANAL CANCER SCREENING.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $21,825

Program Service Revenue $472,525

Investment Income $13,287

Other Revenue $0

TOTAL REVENUE $507,637

Expense Breakdown

Grants Paid $0

Salaries & Benefits $208,355

Fundraising Expenses $0

Program Expenses $518,320

Other Expenses $309,965

TOTAL EXPENSES $518,320

Year-over-Year Comparison

	2025	2024	Change
Revenue	$507,637	$285,159	+0.8%
Expenses	$518,320	$255,134	+1.0%
Net Income	$-10,683	$30,025	-1.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
TROY GRENNAN MD FRCPC	PRESIDENT EL	2.00	Officer Director	$0	$0	$0
MICHELLE KHAN	SECRETARY	2.00	Officer Director	$0	$0	$0
DAVID CHROMY MD	BOARD MEMBER	2.00	Director	$0	$0	$0
ISABELLA ROSA-CUNHA MD	BOARD MEMBER	2.00	Director	$0	$0	$0
JOSEPH TERLIZZI MD	BOARD MEMBER	2.00	Director	$0	$0	$0
JUAN DE LA OSSA MD	BOARD MEMBER	2.00	Director	$0	$0	$0
LUIS BARROSO MD	PAST PRESIDE	2.00	Officer Director	$0	$0	$0
NAOKATSU ANDO MD	BOARD MEMBER	2.00	Director	$0	$0	$0
RICHARD TURNER MD	TREASURER	2.00	Officer Director	$0	$0	$0
ROBERT PAOLO IACHETTA MD	BOARD MEMBER	2.00	Director	$0	$0	$0
URSKA KOGOSEK MD	BOARD MEMBER	2.00	Director	$0	$0	$0
TAMZIN CUMING MBBS FRCS MED	PRESIDENT	2.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$507,637	$518,320	$460,484	$-10,683
2024	$285,159	$255,134	$477,165	$30,025
2023	$549,514	$436,622	$460,657	$112,892
2022	$326,138	$343,111	$337,598	$-16,973
2019	$323,424	$286,847	$271,886	$36,577
2018	$337,809	$247,319	$234,688	$90,490

INTERNATIONAL ANAL NEOPLASIA SOCIETY INC